Join
Live feed
·
NEWSReleasevia Quantisnow
Amneal Pharmaceuticals Inc. logo

Kashiv BioSciences Enters Into Exclusive Licensing Agreement With Amneal For Commercialization Of A Proposed Biosimilar To XOLAIR

ByQuantisnow·Wall Street's wire, on your screen.
AMRX· Amneal Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRX (Amneal Pharmaceuticals Inc.) and more on Quantisnow.